Compare INSE & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSE | PLX |
|---|---|---|
| Founded | 2002 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.3M | 207.1M |
| IPO Year | 2014 | 1996 |
| Metric | INSE | PLX |
|---|---|---|
| Price | $3.17 | $2.56 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | 421.2K | ★ 836.2K |
| Earning Date | 11-04-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | ★ $199,800,000.00 | $52,744,000.00 |
| Revenue This Year | N/A | $55.77 |
| Revenue Next Year | $5.53 | N/A |
| P/E Ratio | ★ N/A | $9.46 |
| Revenue Growth | ★ 30.25 | N/A |
| 52 Week Low | $3.10 | $1.65 |
| 52 Week High | $9.95 | $3.19 |
| Indicator | INSE | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 30.06 | 42.44 |
| Support Level | N/A | $2.21 |
| Resistance Level | $4.03 | $2.75 |
| Average True Range (ATR) | 0.21 | 0.10 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 6.45 | 19.67 |
Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.